Additional Imaging may Benefit Patients With Primary Hyperparathyroidism and Discordant Preoperative Localization Studies

ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS 7.19. Integrated Genomic Analysis of Esophageal Adenocarcinoma Identifies DNA Copy Number Changes and Related Gene Expression Alterations That are Associated With Survival. T. E. Godfrey,1 S. Bandla,1 Z. Zhou,2 A. Pennathur,3 V. R. Litle,1 D. G. Beer,5 A. C. Chang,5 L. Lin,5 W. E. Gooding,4 A. Bass,6 A. Dulak,6 A. Almudevar,7 J. D. Luketich3; 1University of Rochester Medical Center Department of Surgery, Rochester, NY; 2University of Rochester Medical Center - Department of Pathology, Rochester, NY; 3University of Pittsburgh Medical Center Department of Cardiothoracic Surgery, Pittsburgh, PA; 4 University of Pittsburgh, Piitsburgh, PA; 5University of Michigan Medical School, Ann Arbor, MI; 6Dana Farber Cancer Insititute, Boston, MA; 7University of Rochester, Rochester, NY

7.20. EMT-related Brachyury Gene Expression is a Significant Prognostic Factor for Primary Lung Carcinoma. A. Haro, T. Yano, M. Kohno, T. Yoshida, T. Okamoto, Y. Maehara; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka

ONCOLOGY 3: ENDOCRINE NEOPLASMS 8.1. Clinical Significance of Negative Ultrasound and Positive Sestamibi Scan in Patients With Primary Hyperparathyroidism. C. Cen, L. A. Dultz, J. B. Ogilvie, K. S. Heller, K. N. Patel; New York University School of Medicine, New York, NY

8.2. Metastatic Carcinoid Tumors-Are we Making the Cut? K. E. Coan, R. J. Gray, R. T. Schlinkert, B. A. Pockaj, N. Wasif; Mayo Clinic, Phoenix, AZ

8.3. Double Adenoma? Assessment of True, Incidence in Terms of Pathology, Pre-Operative Imaging and Clinical Characteristics. P. K. Shah, K. K. Shah, G. C. Karakousis, C. Reinke, R. Kelz, D. L. Fraker; University of PennsylvaniaDivision of Endocrine and Oncologic Surgery, Philadelphia, PA

8.4. Is BRAF a Cost-Effective Marker for Indeterminate Thyroid Lesions? N. H. Patel, L. A. Dultz, J. B. Ogilvie, K. S. Heller, K. N. Patel; New York University School of Medicine, New York, NY

8.5. MicroRNA Profiles Distinguish Papillary Thyroid Cancers of Varying Aggressiveness. J. C. Lee,1,2 J. Zhao,1 A. Gill,3 M. S. Sywak,2 L. W. Delbridge,2 S. B. Sidhu1,2; 1Kolling Institute of Medical Research, Sydney, NSW; 2University of Sydney Endocrine Surgical Unit, Sydney, NSW; 3Department of Pathology, Sydney, NSW

8.6. Aggressive Surgical Management Best Serves Patients With Small Intestinal Neuroendocrine Tumors. L. R. Imhoff,1 J. Keiser,2 E. Bergsland,2 E. K. Nakakura2; 1 University of California San Francisco - East Bay, Oakland, CA; 2University of California - San Francisco, San Francisco, CA

195

8.7. Role of Adrenal Vein Sampling (Avs) in Patients With Primary Hyperaldosteronism and Unilateral Adrenal Mass by Imaging. K. K. Shah,1 P. K. Shah,1 R. T. Lewis,1 G. C. Karakousis,1 R. Kelz,1 S. Trerotola,2 D. Cohen,2 D. L. Fraker1; 1University of Pennsylvania - Division of Endocrine and Oncologic Surgery, Philadelphia, PA; 2University of Pennsylvania, Philadelphia, PA

8.8. Impact of Surgical Mentorship on Retroperitoneoscopic Adrenalectomy With Comparison to Transperitoneal Laparoscopic Adrenalectomy. J. T. Broome, C. C. Solorzano; Vanderbilt University Medical Center Department of Surgery, Nashville, TN

8.9. Additional Imaging may Benefit Patients With Primary Hyperparathyroidism and Discordant Preoperative Localization Studies. C. Cen, L. A. Dultz, J. B. Ogilvie, K. S. Heller, K. N. Patel; New York University School of Medicine, New York, NY

8.10. The Disparity in Thyroid Cancer Incidence Between Native South Korean and Korean-American Women. A. K. Arrington, R. Nelson, L. Uyeno, S. L. Chen, J. Kim, J. H. Yim; City of Hope National Medical Center, Duarte, CA

8.11. Hereditary Medullary Thyroid Cancer: Age-Appropriate Thyroidectomy Improves Disease-Free Survival. K. H. Shepet, A. Y. Alhefdhi, N. Lai, H. Mazeh, R. Sippel, H. Chen; University of Wisconsin, Madison, WI

8.12. Disparate Gland Weight in Multigland Primary Hyperparathyroidism? A Surgical Caveat. L. A. Dultz, J. B. Ogilvie, K. S. Heller, K. N. Patel; New York University School of Medicine, New York, NY

8.13. Radioactive Iodine: An Unlikely Cause of Primary Hyperparathyroidism. A. L. Amin, S. Wu, T. W. Yen, K. Doffek, T. S. Wang; Medical College of Wisconsin, Milwaukee, WI

8.14. Factors That Influence Parathyroid Hormone Half-life: Are New Intraoperative Criteria Needed? A. J. Leiker, T. W. Yen, D. C. Eastwood, K. Doffek, A. Szabo, D. B. Evans, T. S. Wang; Medical College of Wisconsin, Milwaukee, WI

8.15. Routine Thyroid Lobectomy for Thyroid Nodules on the Same Side of a Localized Parathyroid Adenoma During Directed Parathyroidectomy May Reduce Reoperative Thyroid Surgery. L. Potdevin, T. Davidov, S. Z. Trooskin; UMDNJ - Robert Wood Johnson School of Medicine, New Brunswick, NJ 8.16. Is Intra-operative Parathyroid Hormone Monitoring Necessary in Patients With Two Concordant Preoperative Localization Studies? C. Cen, L. A. Dultz, J. B. Ogilvie, K. S. Heller, K. N. Patel; New York University School of Medicine, New York, NY